Tumor grade and progesterone receptor status in predicting benefit of chemotherapy in high genomic risk breast cancer.

Ke LiuGui-Ping ChenXue-Qin ChenSan-Gang Wu

Published in: Expert review of anticancer therapy (2024)

Our study aids in refining patient selection for the RS testing, which is crucial given its economic implications. However, 21-gene RS remains pivotal for treatment decision-making.

Keyphrases

decision making
copy number
case report
locally advanced
antiretroviral therapy
radiation therapy
young adults
binding protein
transcription factor
replacement therapy
childhood cancer